Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccination

Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccination

US Patent 12186275 · Granted Jan 7, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for reducing immunogenicity of RNA2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Tumor antigens for determining cancer therapy2025
Tumor antigens for determining cancer therapy2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Binding agents binding to EpCAM and CD1372025
Modification of RNA, producing an increased transcript stability and translation2025
Use of RNA for reprogramming somatic cells2025
Trans-replicating RNA2025
RNA replicon for reprogramming somatic cells2025
5′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabi2025
RNA replicon for versatile and efficient gene expression2025